BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17848227)

  • 21. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
    McQuellon RP; Loggie BW; Fleming RA; Russell GB; Lehman AB; Rambo TD
    Eur J Surg Oncol; 2001 Feb; 27(1):65-73. PubMed ID: 11237495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis].
    Mansvelt B; Bertrand C; Nockerman P; Arnould P; Delvaux P; Lechien X; de Neve de Roden A
    Ann Chir; 1997; 51(1):60-7. PubMed ID: 9309889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
    Müller H; Nakchbandi V
    Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.
    Krane LS; Kader AK; Levine EA
    J Surg Oncol; 2012 Mar; 105(3):258-60. PubMed ID: 22271499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
    Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
    J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of regional treatment for peritoneal carcinomatosis.
    Lanuke K; Mack LA; Temple WJ
    Am J Surg; 2009 May; 197(5):614-8; discussion 618. PubMed ID: 19393354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study.
    Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S475-82. PubMed ID: 21837528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anaesthesiologic problems about hyperthermic intraoperative intraperitoneal chemotherapy].
    Izzo L; Pierannunzi F; Vari A; Riccardi S; Tarquini S; Fermariello A; Di Giorgio A; Casullo A; Caputo M; Costi U; Al Radhi H; Kharrub Z; Gazzanelli S
    G Chir; 2004 Oct; 25(10):361-4. PubMed ID: 15756960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
    J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
    Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
    Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
    Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
    Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
    Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
    Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Czech experience in peritonectomy and hyperthermic perioperative cytostatic lavage in the treatment of peritoneal malignancy].
    Antos F; Serclova Z; Gilbert Z; Skala M; Vitek P
    Zentralbl Chir; 2004 Apr; 129(2):153-6. PubMed ID: 15106050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.